The Graft-Versus-Myeloma Effect: Chronic Graft-Versus-Host Disease but Not Acute Graft-Versus-Host Disease Prolongs Survival in Patients with Multiple Myeloma Receiving Allogeneic TransplantationMichèle L. Donato, Scott D. Rowley, David S. Siegel et al.|Transplantation and Cellular Therapy|2014Cited by 54
Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 PatientsSudarsan Kollimuttathuliam, Michèle L. Donato, Phyllis McKiernan et al.|Blood|2019Cited by 4
Haploidentical Allogeneic Transplantation As Salvage in Relapsed Multiple MyelomaPhyllis McKiernan, Michèle L. Donato, Melissa Baker et al.|Blood|2014Cited by 3
Evomela® Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell TransplantationMarshall McKenna, Michèle L. Donato, Phyllis McKiernan et al.|Blood|2019Cited by 2
Day 90 Post-Allogeneic Hematopoietic Cell Transplantation T Cell Receptor Diversity Level Correlates with Risk of Relapse in Patients with Multiple MyelomaRobert Korngold, Michèle L. Donato, Kira Goldgirsh et al.|Blood|2017Cited by 2